The future of small businesses depends on affordable healthcare By Marcie Strouse Key Points Small businesses face a severe affordability crisis in providing employer-sponsored health insurance, with premiums rising more than 120 percent since 2000 an... Read more FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6 MOST VIEWED 1 Ohio bill among several in the nation seeking to expand the role of optometrists 2 Millions newly eligible for HSAs in 2026 after rule change 3 Easing Ohio’s care provider shortage 4 With America’s healthcare system failing, it’s time for fresh thinking DONATE
FDA moves to tighten vaccine rules after internal review links COVID-19 vaccines to child deaths By HPN staff Key Points The FDA is considering significantly stricter approval standards for vaccines, including COVID-19, flu, pneumonia and vaccines for pregnant women, following an inte... Read more States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
States apply for historic $50 billion investment to rescue rural health By HPN staff Key Points All 50 states have applied for the federal government’s new $50 billion Rural Health Transformation Program, the largest rural health investment in U.S. history, ai... Read more FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
FDA issues new — and controversial — guidance on fluoride for young children By HPN Staff Key Points The FDA announced that children under age 3 should not receive ingestible fluoride products (tablets or drops), even in low-to-moderate-cavity-risk groups, marking ... Read more States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
States begin to put legislative guardrails on artificial intelligence By HPN Staff Key Points AI adoption in healthcare is accelerating, prompting states to introduce more than 250 bills this year—shifting from studying AI to imposing binding rules on transp... Read more Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
Trump’s drug price deal could bring relief to the states By HPN Staff Key Points The Trump Administration’s agreement with Novo Nordisk and Eli Lilly will cut the cost of GLP-1 drugs like Wegovy and Zepbound from about $1,000+ per month to $50–$... Read more Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
Stop spending Medicaid money on ineffective programs By Linda Gorman Key Points State Medicaid programs are urged to end funding for doula services, as existing research, including a randomized controlled trial in Illinois, shows no meaningf... Read more Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
Momentum grows to modernize menopause care as FDA weighs new guidance BY HPN Staff Key Points The Food and Drug Administration (FDA) is reevaluating the “black box” warning on hormone replacement therapy (HRT) for menopause, given new research showing that w... Read more Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more 1 2 3 4 5 6
Michigan House bill will increase drug price transparency Key Points What began as a program to help hospitals provide affordable care to low-income patients has expanded from $6 billion in 2010 to $66 billion today, with many hospitals now using it to ... Read more Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more
Committee takes unexpected turn on COVID vaccine for pregnant women Key Points The CDC’s Advisory Committee on Immunization Practices (ACIP) quietly reinstated COVID vaccine eligibility for pregnant women under a “shared clinical decision making” model, reversing... Read more
